Stocksigma LogoStocksigma Logo

Gufic Biosciences Reports Strong Q2 FY27 Consolidated Results with PAT Up 39.5% YoY

Gufic Biosciences reported consolidated revenue from operations of ₹28,827.30 lakh for the quarter ended 30th Sep'26, up 21.6% YoY from ₹23,705.45 lakh and

Gufic Biosciences Reports Strong Q2 FY27 Consolidated Results with PAT Up 39.5% YoY

Gufic Biosciences Ltd · Financial Result · 15 Nov 2026, 1:52 am

Gufic Biosciences Reports Strong Q2 FY27 Consolidated Results with PAT Up 39.5% YoY Gufic Biosciences reported consolidated revenue from operations of ₹28,827.30 lakh for the quarter ended 30th Sep'26, up 21.6% YoY from ₹23,705.45 lakh and up 10.5% QoQ from ₹26,081.80 lakh. Profit before tax rose 39.1% YoY to ₹3,144.74 lakh compared to ₹2,260.41 lakh in Q2 FY26. Consolidated net profit reached ₹2,346.89 lakh, registering a 39.5% YoY growth against ₹1,682.40 lakh in the prior-year period. Basic and diluted EPS improved to ₹2.34 from ₹1.68 YoY. For H1 FY27, net profit expanded 53.1% YoY to ₹4,578.17 lakh.

Original exchange filing (PDF)

More announcements from Gufic Biosciences Ltd

All Gufic Biosciences Ltd announcements